Release Date: 09/03/18 16:40 Summary: Notice of On Market Share Buy-Back Price Sensitive: No Download Document 502.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%